Express Scripts Holding Co (ESRX)

ESRX (NASDAQ:Health Services) EQUITY
$83.49
pos +1.56
+1.90%
Today's Range: 82.19 - 83.52 | ESRX Avg Daily Volume: 4,261,400
Last Update: 09/02/15 - 4:14 PM EDT
Volume: 3,169,691
YTD Performance: -3.24%
Open: $83.02
Previous Close: $81.93
52 Week Range: $68.06 - $94.61
Oustanding Shares: 675,731,000
Market Cap: 56,491,111,600
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 10 10
Moderate Buy 2 2 2 2
Hold 9 9 9 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.93 1.93 1.93 1.88
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 27.68
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
27.68 27.50 24.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-4.73% 10.82% 30.84%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 1.19 0.29
Net Income 8.70 0.60 0.17
EPS 17.90 0.05 0.02
Earnings for ESRX:
EBITDA 5.85B
Revenue 100.89B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.44 $1.53 $5.50 $6.06
Number of Analysts 13 12 15 15
High Estimate $1.46 $1.56 $5.52 $6.15
Low Estimate $1.43 $1.50 $5.49 $5.95
Prior Year $1.29 $1.39 $4.88 $5.50
Growth Rate (Year over Year) 11.69% 10.25% 12.76% 10.06%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 30, 2015 | 8:30 AM EDT

Some big changes were made to the Action Alerts PLUS portfolio this week as its position in Kinder Morgan (KMI) was closed and new positions were opened.

By

David Katz

 | May 29, 2015 | 8:30 AM EDT

Will it get involved in health care sector's deal mania?

By

Jim Cramer

 | May 27, 2015 | 3:47 PM EDT

Buy at right price and have courage to hold.

updateExpress Scripts rated new Neutral at Baird

May 20, 2015 | 7:48 AM EDT

ESRX was initiated with a Neutral rating, Robert Baird said. $94 price target. Valuation call, given the company's lower growth potential. 

 

By

Jim Cramer

 | Apr 30, 2015 | 11:57 AM EDT

AmerisourceBergen, Cigna, NXP Semi tell where the market's going.

By

David Katz

 | Apr 21, 2015 | 1:05 PM EDT

Teva bid highlights M&A action in health care sector.

By

David Katz

 | Apr 21, 2015 | 12:53 PM EDT

Teva bid highlights M&A action in health care sector.

By

David Katz

 | Apr 10, 2015 | 8:00 AM EDT

Drug franchises are still going strong.

By

James "Rev Shark" DePorre

 | Apr 9, 2015 | 4:10 PM EDT

With trading so dull, what do you expect?

By

Bret Jensen

 | Apr 6, 2015 | 9:30 AM EDT

I am growing pessimistic about the market's upside potential.

Been having very interesting exchanges on Twitter (started last night) about McDonald's --...
Nice to have a solid day in the market after yesterday big decline especially a rally that...
In mid July WHR held key support near the $160.00 area after blowing out support near...
Will a 250,000 print on the jobs data on Friday seal the deal for the Fed and allow them t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.